Author

Peter C. Fridy

Rockefeller UniversityORCID 0000-0002-8208-9154Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:structural biology· 1

Frequent Co-Authors

Brian T. ChaitiD· 2 shared Michael P. RoutiD· 2 shared Andrej ŠaliiD· 1 shared Athanasios D. Bakasis· 1 shared Deena A. OreniD· 1 shared Frederick R. CrossiD· 1 shared J. B. BonannoiD· 1 shared Jesse Jenkins· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Brian T. ChaitORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 3, 2026

Multivalent Anti-ACE2 Nanobodies Confer Broad Pan-Sarbecovirus Protection

Athanasios D. Bakasis, Rachel Patejak, Peter C. Fridy…·Théodora Hatziioannou

This study develops multivalent anti-ACE2 nanobodies that broadly neutralize SARS-CoV-2 variants and sarbecoviruses with high potency and efficacy in animal models.

DOI 10.64898/2026.09.01.748598

humanexperimental assay

𝕏 PostBluesky

BiochemistryStructurePeer-reviewedFeb 11, 2025

Unique Binding and Stabilization Mechanisms Employed By and Engineered Into Nanobodies.

Natalia E. Ketaren, Peter C. Fridy, Vladimir N. Malashkevich…·Michael P. Rout

This study identifies mechanisms enabling nanobodies to bind antigens with high affinity and stability, revealing a conserved region critical for their function and suggesting strategies for their optimization.

22 citationstop 2%

structural biologyexperimental assay

𝕏 PostBluesky